Clin Oncol | Volume 7, Issue 1 | Case Report | Open Access

Malignant Struma of the Ovary: Own Clinical Observation

Kiseleva MV¹, Denisov MS¹, Lunkova MN¹, Karibayeva ShK² and Litvyakova EV^1*

¹A. Tsyb Medical Radiological Research Center, National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (A. Tsyb MRRC) 249036, Russia
²International Clinical Center of Reproductology PERSONA, Kazakhstan

^*Correspondance to: Litvyakova Elena Viktorovna 

Abstract

Ovarian teratomas account for 15% to 20% of all ovarian tumors. Ovarian Struma (OS) in most cases (up to 50%) refers to monodermal mature ovarian teratoma and is a fairly rare tumor consisting of thyroid tissue. This type of neoplasm accounts for 1% of all ovarian tumors and 2.7% of all dermoid formations. The diagnosis of "ovarian struma" is made if the thyroid tissue is more than 50% of the tumor tissue. The article describes his own experience in managing a patient with a diagnosis of "Malignant struma of the ovary". Data on the clinical and morphological features of the disease are given.

Citation:

Kiseleva MV, Denisov MS, Lunkova MN, Karibayeva ShK, Litvyakova EV. Malignant Struma of the Ovary: Own Clinical Observation. Clin Oncol. 2022;7:1978..